4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001209191-20-011812
Chairman and CEO bought 48,000 shares at an average $1.80 ($86,580)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Niihara Yutaka Chairman and CEO | 2020-02-19 | Purchase | +8,000 | $1.70 | $13,600 | 10,368,543 | D |
| Niihara Yutaka Chairman and CEO | 2020-02-20 | Purchase | +15,500 | $1.80 | $27,900 | 10,384,043 | D |
| Niihara Yutaka Chairman and CEO | 2020-02-21 | Purchase | +24,500 | $1.84 | $45,080 | 10,408,543 | D |
| Open-market purchases · 48,000 sh · avg $1.80 · $86,580 | |||||||
Loading xslF345X03/doc4.xml…